Pharmacological properties of 3-n-butylamino-4-phenoxy-5-sulfamylbenzoic acid (Bumetanide), a new potent diuretic.
D000284:Administration, Oral; D000818:Animals; D002082:Butylamines / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D004285:Dogs; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D009318:Natriuresis / Q000187:drug effects; D010636:Phenols / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity; D051381:Rats; D013449:Sulfonamides / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity
D002082:Butylamines; D004232:Diuretics; D010636:Phenols; D013449:Sulfonamides